BVMed calls for transparency in assessing new technology
This article was originally published in Clinica
Executive Summary
The German industry association BVMed has issued a three-point statement demanding more transparency in the evaluation process of medical devices by the Bundesausschuss Arzte und Krankenkassen (federal committee of statutory health insurance physicians and sickness funds) and the Bundesausschuss Krankenhaus (federal committee of hospitals). It has also called for the establishment of centres of excellence to monitor the performance of innovative devices immediately after their market launch.